This brochure provides a comprehensive overview of Ace Therapeutics' animal models and technology platforms for stroke research. Our diverse models allow for comprehensive evaluation of therapeutics with behavioral, molecular, and histological assessments.
Download our brochure to explore how our solutions can accelerate your stroke research and help you develop innovative therapies.
Our Capabilities
A systematic introduction to Ace Therapeutics' preclinical stroke research capabilities and cutting-edge technology platforms.
Our customized in vitro models of stroke and advanced cell-based assay platform accelerate the discovery of novel stroke therapies.
The intraluminal filament tMCAO is a widely used experimental model to mimic focal cerebral ischemia followed by reperfusion, studying disease mechanisms and treatments.
Photochemical thrombosis is a method for the induction of ischemic stroke in the cerebral cortex, which aids in stroke mechanism and therapy development.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.